{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:04:33Z","timestamp":1748837073316,"version":"3.41.0"},"reference-count":17,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.3892\/mco.2016.782","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T10:09:48Z","timestamp":1455617388000},"page":"824-826","source":"Crossref","is-referenced-by-count":1,"title":["Paralytic ileus due to a novel anticancer drug, nab-paclitaxel: A case report"],"prefix":"10.3892","volume":"4","author":[{"given":"XIAO-DONG","family":"JIAO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XIU","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WEN-XING","family":"QIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LING-YAN","family":"YUAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUAN-SHENG","family":"ZANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"key20180107145737_b1-mco-0-0-782","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1517\/14740338.2014.893293","article-title":"Safety and efficacy evaluation of albumin-bound paclitaxel","volume":"13","author":"Cecco","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"key20180107145737_b2-mco-0-0-782","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2013.05.041","article-title":"Nab-Paclitaxel mechanisms of action and delivery","volume":"170","author":"Yardley","year":"2013","journal-title":"J Control Release"},{"key":"key20180107145737_b3-mco-0-0-782","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-012-2341-9","article-title":"Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen","volume":"137","author":"Yardley","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107145737_b4-mco-0-0-782","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180107145737_b5-mco-0-0-782","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","article-title":"Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: Final results of a phase III trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107145737_b6-mco-0-0-782","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jjco\/hyu205","article-title":"A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial)","volume":"45","author":"Koizumi","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"key20180107145737_b7-mco-0-0-782","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14656566.2012.651127","article-title":"Enhancing intracellular taxane delivery: Current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer","volume":"13","author":"Guarneri","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"key20180107145737_b8-mco-0-0-782","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4137\/BCBCR.S5857","article-title":"Safety and efficacy of nab-paclitaxel in the treatment of patients with breast cancer","volume":"5","author":"Vishnu","year":"2011","journal-title":"Breast Cancer (Auckl)"},{"key":"key20180107145737_b9-mco-0-0-782","first-page":"181269","article-title":"Sub-tenon injections of triamcinolone acetonide had limited effect on cystoid macular edema secondary to nanoparticle albumin-bound-paclitaxel (Abraxane)","volume":"2015","author":"Matsuoka","year":"2015","journal-title":"Case Rep Ophthalmol Med"},{"key":"key20180107145737_b10-mco-0-0-782","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00280-014-2607-5","article-title":"Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer","volume":"75","author":"Rivera","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107145737_b11-mco-0-0-782","first-page":"7267","article-title":"Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer","volume":"34","author":"John","year":"2014","journal-title":"Anticancer Res"},{"key":"key20180107145737_b12-mco-0-0-782","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/jop.2011.0178","article-title":"Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): Clinical experience with intravitreal bevacizumab","volume":"29","author":"Rahman","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"key20180107145737_b13-mco-0-0-782","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/1471-2407-13-542","article-title":"Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease","volume":"13","author":"Gardini","year":"2013","journal-title":"BMC Cancer"},{"key":"key20180107145737_b14-mco-0-0-782","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00001813-199803000-00001","article-title":"Gemcitabine-a safety review","volume":"9","author":"Aapro","year":"1998","journal-title":"Anticancer Drugs"},{"key":"key20180107145737_b15-mco-0-0-782","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2012.09.008","article-title":"Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study","volume":"127","author":"Alberts","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107145737_b16-mco-0-0-782","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-1018908","article-title":"In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats","volume":"14","author":"Yagihashi","year":"1982","journal-title":"Horm Metab Res"},{"key":"key20180107145737_b17-mco-0-0-782","first-page":"183","article-title":"Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy","volume":"9","author":"Ide","year":"1987","journal-title":"Clin Ther"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.782\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T11:48:23Z","timestamp":1748778503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,2,16]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.3892\/mco.2016.782"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.782","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}